The biotechnology, chemical, and pharmaceuticals (BCP) technology
groups at the U.S. Patent and Trademark Office will hold their next quarterly customer partnership meeting on December 3, 2008.
The schedule of topics for discussion include (all times Eastern):
Morning Session
• Greetings and Overvie (9:00 - 9:15 AM): John LeGuyader, George Elliot, and Remy Yucel, Directors, Technology Center 1600
• TC1600 Chemical Non-Statutory Double Patenting Examples (9:15 - 10:00 AM): Daniel Sullivan SPE, Art Unit 1621
• Personalized Medicine (10:00 - 10:45 AM): Kathleen Bragdon, QAS, TC 1600
• Break (10:45 - 11:00 AM)
• Restriction Burden and Petition Data (11:00 AM - 12:00 PM): Julie Burke, QAS, TC 1600
• Lunch (12:00 - 1:15 PM)
Afternoon Session
• Overview of New Rules before the Board of Patent Appeals and Interferences (1:15 - 2:00 PM): Michael Fleming, Chief Administrative Patent Judge, BPAI
• Searching in Applications Containing Bio-Sequences (2:00 - 2:45 PM): Ram Shukla, SPE, Art Unit 1634
• Break (2:45 - 3:00 PM)
• TC Training – How to Read Case Law (3:00 - 4:00 PM): Janet Gongola, Associate Solicitor Office of the Solicitor
• Closing Remarks/Discussion (4:00 - 4:15 PM): John LeGuyader, George Elliot, and Remy Yucel, Directors, Technology Center 1600
The BCP meeting can be attended in person at Madison Auditorium (600 Dulany Street, Alexandria, VA), or it can be viewed over the the internet at: https://uspto.connectsolutions.com/bcp120308/.
Comments